This Week’s Biotech Highlights
Things were heating up in the world of biotech this week!
Hot deals — some of the biggest numbers Canadian companies have seen this year:
- Bioniche licensed its Urocidin product to U.S.-based Endo Pharmaceuticals for $20 million up front and the potential for over $110 million more; and
- Allostera raised $17 million in venture capital.
Hot entrepreneurs — new sources of capital and new training bode well for a fresh crop of companies:
- Teralys Capital opened the doors to start spending its $700 million fund; and
- Two new initiatives — one in Waterloo and one in Ottawa
